Vaccine Development

Tsingke Biotech provides an integrated platform for vaccine research and development, spanning antigen design, nucleic acid synthesis, vector construction, and large-scale manufacturing. With in-house reagents, self-developed instruments, and GMP-ready production lines, we deliver high-quality vaccine components and intermediates to accelerate the journey from laboratory discovery to clinical trials and commercialization. Our solutions support multiple vaccine modalities, including mRNA vaccines, protein subunit vaccines, and viral vector vaccines.

Types of Vaccine Development

Advantages of Tsingke Vaccine Development

End-to-End Capability

From nucleic acid design to antigen production and delivery formulation.

Flexible Modalities

Support for mRNA, protein subunit, and viral vector vaccine platforms.

In-House Manufacturing

Reagents, instruments, and production facilities under direct quality control.

Regulatory Readiness

GMP-compliant processes and documentation support for IND filings.

Fast Turnaround

Optimized workflows to accelerate vaccine candidate development.

Contact Us

Explore the power of the Gene Factory and discover how Tsingke's integrated platform accelerates your R&D and product development.

Tsingke Updates

2025-12-15

Biologics 2024



2025-11-25

Gene Synthesis: A Booster for the Development of Biological Breeding



Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights.

Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!

Sitemap | Privacy Policy

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.

Reject Accept